Entera Bio Statistics
Entera Bio (5DT) Stock Statistics & Valuation Metrics
Total Valuation
Entera Bio has a market cap or net worth of EUR 491.34M. The enterprise value is EUR 150.15M.
- Market Cap
- EUR 491.34M
- Enterprise Value
- EUR 150.15M
Share Statistics
Entera Bio has 174,137,770 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 174,137,770
- Owned by Insiders
- 1.34%
- Owned by Institutions
- 21.08%
Financial Efficiency
Entera Bio’s return on equity (ROE) is -0.87 and return on invested capital (ROIC) is -218.81%.
- Return on Equity (ROE)
- -0.87
- Return on Assets (ROA)
- -0.72
- Return on Invested Capital (ROIC)
- -218.81%
- Return on Capital Employed (ROCE)
- -0.84
- Revenue Per Employee
- 1,555.556
- Profits Per Employee
- -423.67K
- Employee Count
- 27
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Entera Bio is -8.00. Entera Bio’s PEG ratio is 0.18.
- PE Ratio
- -8.00
- PS Ratio
- 0.00
- PB Ratio
- 1.64
- Price to FCF
- -33.78
- Price to Operating Cash Flow
- -28.23
- PEG Ratio
- 0.18
Income Statement
In the last 12 months, Entera Bio had revenue of 42.00K and earned -11.44M in profits. Earnings per share was -0.25.
- Revenue
- 42.00K
- Gross Profit
- 0
- Operating Income
- -11.53M
- Pretax Income
- -11.44M
- Net Income
- -11.44M
- EBITDA
- -11.41M
- Earnings Per Share (EPS)
- -0.25
Cash Flow
In the last 12 months, operating cash flow was -15.98M and capital expenditures -53,836, giving a free cash flow of -16.03M billion.
- Operating Cash Flow
- -15.98M
- Free Cash Flow
- -16.03M
- Free Cash Flow per Share
- -0.11
Dividends & Yields
Entera Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.96%
- Earnings Yield
- -6.52%
Stock Price Statistics
- Beta
- 0.68
- 52-Week Price Change
- 20.93%
- 50-Day Moving Average
- 2.49
- 200-Day Moving Average
- 1.68
- Relative Strength Index (RSI)
- 64.05
- Average Volume (3m)
- 794
Important Dates
Entera Bio upcoming earnings date is Mar 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 26, 2027
- Ex-Dividend Date
- ―
Financial Position
Entera Bio as a current ratio of 3.23, with Debt / Equity ratio of 3.74%
- Current Ratio
- 3.23
- Quick Ratio
- 3.23
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.58
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Entera Bio has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Entera Bio EV to EBITDA ratio is -15.07, with an EV/FCF ratio of -17.22.
- EV to Sales
- 0.00
- EV to EBITDA
- -15.07
- EV to Free Cash Flow
- -17.22
- EV to Operating Cash Flow
- -17.28
Balance Sheet
Entera Bio has EUR 265.88M in cash and marketable securities with EUR 397.00K in debt, giving a net cash position of EUR 265.49M billion.
- Cash & Marketable Securities
- EUR 265.88M
- Total Debt
- EUR 397.00K
- Net Cash
- EUR 265.49M
- Net Cash Per Share
- EUR 1.52
- Tangible Book Value Per Share
- EUR 1.89
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Entera Bio is EUR 8.91, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- EUR 8.91
- Price Target Upside
- 211.55% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 4
- Revenue Growth Forecast
- -100.00%
- EPS Growth Forecast
- -52.24%
Scores
- Smart Score
- 6
- AI Score
- ―

